Jaia Robotics specializes in the development of microsized autonomous and subsurface marine vehicles intended to revolutionize aquatic data collection. The company offers a multi-sensor configurable technology that is user-friendly and requires minimal training, significantly enhancing the efficiency and affordability of data collection compared to conventional crewed or uncrewed systems. By providing comprehensive data collection services, Jaia Robotics enables clients to access valuable aquatic data with improved ease and effectiveness.
Theromics Inc. develops cell therapies. It offers HeatSYNC Gel, a thermal accelerant (TA) that augments MW and RF energy by increasing local tissue electrical conductivity in a reproducible and effective manner. The company’s TA absorbs microwave energy effectively preventing heat loss caused by blood flow in large vessels adjacent to ablation zone; optimizes the shape of the ablation zone into a circle making the ablation volume predictable; and produces a larger ablation area making it easier to target the tumor center and with 3-D modeling optimizes antenna guidance into tumor mass. Theromics Inc. was founded in 2016 and is based in West Bridgewater, Massachusetts.
AOA, based in Boston, New York, and London, is a female-led company focused on developing innovative cancer diagnostics specifically for women's health. The company is dedicated to creating the first accurate early-stage liquid biopsy test for ovarian cancer, which aims to enhance clinical practices, reduce patient mortality, and offer cost savings for healthcare payers. Utilizing an artificial intelligence-enabled platform, AOA's technology analyzes tumor marker gangliosides to facilitate the early detection of ovarian cancer. This approach not only helps healthcare providers implement more effective treatment strategies but also ensures that patients can access life-saving treatments sooner and at a more affordable cost.
Lenoss Medical engages in providing solutions that support the natural osseous healing process.
First Light Biosciences develops breakthrough automated medical diagnostic products for rapid, sensitive, and cost-effective detection of Healthcare-Associated Infections (HAI). The products address the need for cost-effective and accurate diagnostics to meet the explosive growth in testing. New testing is being driven by clinical studies showing that testing for infectious agents can help to dramatically lower the rate of hospital infections. Based on its proprietary MultiPath detection technology, First Light’s products combine the performance of the most advanced commercial laboratory tests with unprecedented affordability and ease-of-use.
Spiro Technologies, Inc. is a Boston-based company that develops a relationship management platform designed to assist sales teams across various industries, including construction, finance, manufacturing, professional services, and technology. Founded in 2014, Spiro's platform operates in the background to automate data collection from emails, calls, and texts, eliminating the need for manual data entry. It creates and organizes contacts, prioritizes sales opportunities, and generates intelligent reports to enhance sales performance. Additionally, the platform offers features such as sales suggestions and tools for tracking and managing customer interactions, ultimately enabling businesses to optimize engagement and prevent lost opportunities.
RevBio is commercializing an injectable, self-setting bone adhesive that can bond bone to bone and bone to metal to stabilize implant devices. Over time, the adhesive biodegrades and is replaced by new bone. This unique material will reduce the duration and complexity of medical procedures, allow for more minimally invasive surgeries, and will improve patient outcomes by reducing recovery time and the overall cost of care.
Orange Photonics, Inc. specializes in providing quality control and data analytics products for the legal cannabis industry. Based in Elkins, New Hampshire, the company develops solutions for a variety of stakeholders, including growers, dispensaries, regulators, and manufacturers of infused products. Its flagship product, the LightLab, is a portable, lab-grade cannabis potency analyzer designed for on-site testing and tracking of cannabis potency. This innovative tool aims to set a new standard for accurate, repeatable, and cost-effective potency testing. In addition to the LightLab, Orange Photonics plans to offer services that facilitate data collection and analysis, enabling customers to make informed, data-driven decisions to enhance their operations within the cannabis market.
Pykus Therapeutics, Inc. was founded in 2016 to develop a dissolvable intraocular surgical device to make retinal surgery less painful and more successful.
The co-founders were ophthalmology residents at the Massachusetts Eye and Ear Infirmary and Harvard Medical School when they developed a novel hydrogel to replace the use of intraocular gas during retinal surgery. This innovation will eliminate the extreme burden placed on patients including the requirement for face-down positioning, inability to see for weeks, and inability to fly for weeks.
XCube R&D provides software infrastructure that automates testing and training process for machine learning algorithms. The company specializes in providing automation for OEMs and auto suppliers developing advanced driver assistance systems (ADAS) and autonomous vehicle programs. It offers StreamX Platform, a web-based interface to capture and store multi-sensor data, tag or annotate data based on the content important to the application, search data during the tagging and mining phase, launch an application, and save and automate a process. The company offers solutions in the areas of test and validation, training classifiers, real-time analysis, and automated regression testing. XCube R&D was founded in 2006 and is based in Nashua, New Hampshire.
Building Conversation offers a unique and innovative augmented reality solution to help real estate developers and architecture firms communicate their ideas more clearly with each other and the general public. Their mobile app offers a variety of highly customizable capabilities directed at streamlining and improving the building proposal process specific to your unique challenges. Small neighborhood store, high end residential or billion-dollar waterfront development and everything in between, arc will make the outcome faster and easier and the process saving you time and money.
Datarista is reinventing how third-party sales & marketing data providers deliver data to their customers. The Datarista platform provides real time, relevant third party data delivery, integration and update services for both enhancement and prospecting inside of the most popular CRM and Marketing Automation platforms. Datarista is a service extension for the data providers to enable their sales teams to sell an end-to-end solution.
Datarista is PaaS for your DaaS!
Xeno Biosciences Inc. is a biotechnology company based in Somerville, Massachusetts, focused on developing innovative treatments for obesity and related metabolic diseases. Founded in 2015, the company is pioneering a novel class of therapeutics designed to mimic the effects of gastric bypass surgery. Its lead product, XEN-101, is an oral formulation that delivers molecular oxygen to the lower gut, facilitating a shift in the gut microbiome toward a state associated with weight loss, similar to the outcomes of Roux-en-Y Gastric Bypass surgery. Through this approach, Xeno Biosciences aims to address significant unmet needs in the management of metabolic disorders.
Concrete Sensors is a manufacturer of wireless sensors that provide real-time data on concrete curing processes, enabling general contractors to make informed decisions. Founded in 2014 and based in Cambridge, Massachusetts, the company specializes in embedded sensors that analyze concrete as it cures, reporting critical metrics such as strength, temperature, and relative humidity. Utilizing established methods and a comprehensive library of concrete mixes, the sensors offer mobile access to data, allowing users to monitor whether the curing conditions are suitable, determine the optimal time to remove forms, and assess when to proceed with subsequent work. This technology aids in ensuring the integrity and quality of concrete structures, streamlining construction operations.
Siamab Therapeutics is a biopharmaceutical company that develops therapies targeting abnormal carbohydrates found only on cancer cells. It has developed a platform of technologies that enables the discovery and development of anti-TACA therapeutic antibodies.
The company’s core technologies were licensed from the laboratory of Ajit Varki, a professional in glycobiology and sialic-acid biochemistry. It has brought together a team of scientists and advisors in oncology, glycoimmunology, and antibody engineering to support its anti-TACA antibody discovery and development programs.
Siamab Therapeutics was founded in 2006 and is headquartered in Newton, M.A.
Avaxia Biologics, Inc. operates as a biopharmaceutical company that develops oral antibody therapeutics. It offers gastrointestinal diseases, such as inflammatory bowel diseases, celiac disease, necrotizing enterocolitis, radiation syndrome, oral mucositis, and diabetes and obesity. Avaxia Biologics, Inc. has a strategic collaboration with Courtagen Life Sciences, Inc. The company was founded in 2005 and is based in Lexington, Massachusetts. Avaxia Biologics, Inc. operates as a subsidiary of Circle33 LLC.
MoFuse is a company that offers a web-based platform designed for building and managing mobile websites. Through a subscription service, it enables businesses to effectively deliver mobile media. MoFuse provides a mobile content management system (CMS) that allows users to enhance their mobile sites with various features, including search capabilities, mobile commerce options, click-to-call leads, mobile advertisements, and forms for data capture. Additionally, its premium service supports publishers by offering tools for publishing, promoting, monetizing, and analyzing their mobile properties. This comprehensive approach helps businesses optimize their mobile presence and engage effectively with their audience.
iQuartic, Inc. specializes in developing cloud platforms aimed at data networking and mining within the healthcare sector. The company's technology facilitates essential functions such as EHR and claims auditing, quality benchmarking, population health management, disease management, risk profiling, and revenue optimization. Key offerings include the iQ EHR Network, which integrates disparate EMR systems across various facilities; iQ EHR Auditing, which utilizes advanced analytics to identify inconsistencies in EHR data; and iQ ACO Software, designed for accountable care organizations to analyze networks and patient data comprehensively. Additional products encompass predictive modeling tools like the EHR Data Auditor, which focuses on HIV patient reporting; the Diabetes Management Scorecard; and the COPD Population Profiler, among others. These tools aim to enhance chronic disease management, predict hospital readmissions, and improve clinician profiling. Founded in 2012, iQuartic is headquartered in Boston, Massachusetts.
Avaxia Biologics, Inc. operates as a biopharmaceutical company that develops oral antibody therapeutics. It offers gastrointestinal diseases, such as inflammatory bowel diseases, celiac disease, necrotizing enterocolitis, radiation syndrome, oral mucositis, and diabetes and obesity. Avaxia Biologics, Inc. has a strategic collaboration with Courtagen Life Sciences, Inc. The company was founded in 2005 and is based in Lexington, Massachusetts. Avaxia Biologics, Inc. operates as a subsidiary of Circle33 LLC.
Pixability, Inc. is a video advertising software company that specializes in optimizing campaigns across YouTube and Connected TV. Founded in 2008 and headquartered in Boston, Massachusetts, with additional offices in New York, San Francisco, Chicago, and London, Pixability offers a comprehensive cloud-based platform designed to enhance video marketing efforts. Its software includes tools for campaign creation, benchmarking, testing, and optimization, as well as features for channel management and insights into placements, keywords, and competitive dynamics. The company's PixabilityONE platform is specifically designed for running campaigns across various video advertising destinations, while BrandTrack allows marketers to measure brand performance on YouTube. Pixability serves a diverse clientele, including media buyers, agencies, in-house brand teams, and strategic marketers, leveraging data science to improve the effectiveness of complex advertising campaigns.
Copiun offers a PC backup and User Data Management solution designed to simplify data protection for mid to large enterprises. By focusing on automation and security, Copiun minimizes the burden on end users and IT administrators while significantly reducing costs. The company's approach allows for nearly zero IT intervention, making the solution accessible and efficient. Additionally, Copiun provides mobile collaboration services with end-to-end data governance, enabling secure document sharing on mobile devices. This comprehensive service helps corporations regain control of their distributed data across laptops, desktops, and remote offices, enhancing overall data management and security.
SmartCells, Inc. designs and develops insulin products. It offers SmartInsulin, a self regulating injectable formulation for treating diabetes. The company's polymer-based dosing technology is used for various applications, such as fertility, thyroid, and growth hormone deficiencies; treatments with poor compliance or therapeutic window issues, such as oncology; and drug-device combinations. SmartCells, Inc. was founded in 2003 and is based in Beverly, Massachusetts.
Crimson Hexagon, Inc. is a provider of social media analysis software based in Boston, Massachusetts. Founded in 2007, the company offers an AI-powered consumer insights platform that enables businesses and organizations to gain valuable insights from social data. Its technology allows clients to analyze audiences, track brand perception, evaluate campaign performance, and identify market trends using extensive unstructured text and images sourced from social media, online public platforms, and enterprise-held data. The platform is particularly useful for agencies in their media planning and return on investment assessments. Additionally, Crimson Hexagon supports nonprofit, educational, and research sectors by offering reduced-fee access to its analytics tools. The company serves a diverse clientele that includes major brands such as Anheuser-Busch InBev, Adidas, and Starbucks. As of October 31, 2018, Crimson Hexagon operates as a subsidiary of Runtime Collective Limited.
Tikatok is an online platform that enables children under 13 to write, illustrate, and publish their own stories as real books. Founded by two mothers, Tikatok aims to provide a creative outlet for young children, allowing them to self-publish paperback or hardcover books for under $20. The platform features a user-friendly, template-based system called "story sparks," which assists children in starting their writing and illustration projects. Users can upload artwork directly or send it in via mail. Tikatok also offers group packages for schools and libraries, promoting collaborative creativity. The platform is designed with a family-centered approach and includes a well-considered privacy policy to ensure a safe environment for its young users.
SmartCells, Inc. designs and develops insulin products. It offers SmartInsulin, a self regulating injectable formulation for treating diabetes. The company's polymer-based dosing technology is used for various applications, such as fertility, thyroid, and growth hormone deficiencies; treatments with poor compliance or therapeutic window issues, such as oncology; and drug-device combinations. SmartCells, Inc. was founded in 2003 and is based in Beverly, Massachusetts.
GateRocket, Inc. provides verification and debugging solutions for FPGAs. It offers RocketDrive, a device native verification system for complex FPGAs, which accelerates verification throughput and identifies problems with IP blocks, pin-outs, and tool chain anomalies. The company also provides RocketVision, a FPGA debug solution that automates test point insertion and detects differences between RTL and FPGA devices. The company was incorporated in 2003 and is headquartered in Bedford, Massachusetts.